About CareFusion (NYSE:CFN)
CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNYSE:CFN
CUSIP14170T10
Phone+1-800-6848880
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins16.18%
Return on Equity12.80%
Return on Assets7.62%
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
CareFusion (NYSE:CFN) Frequently Asked Questions
What is CareFusion's stock symbol?
CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."
How were CareFusion's earnings last quarter?
CareFusion Co. (NYSE:CFN) issued its quarterly earnings data on Thursday, February, 5th. The healthcare company reported $0.99 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.79 by $0.20. The healthcare company had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.01 billion. CareFusion had a net margin of 16.18% and a return on equity of 12.80%. The company's quarterly revenue was up 15.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.54 earnings per share. View CareFusion's Earnings History.
Has CareFusion been receiving favorable news coverage?
Media stories about CFN stock have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CareFusion earned a coverage optimism score of 0.20 on Accern's scale. They also gave news headlines about the healthcare company an impact score of 46.33 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
What is CareFusion's stock price today?
One share of CFN stock can currently be purchased for approximately $59.94.
How big of a company is CareFusion?
CareFusion has a market capitalization of $12.24 billion.
How can I contact CareFusion?
CareFusion's mailing address is 3750 Torrey View Ct, SAN DIEGO, CA 92130-2622, United States. The healthcare company can be reached via phone at +1-800-6848880.
MarketBeat Community Rating for CareFusion (CFN)
MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe CFN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CFN will underperform the S&P 500 over the long term. You may vote once every thirty days.
CareFusion (NYSE:CFN) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/23/2016 forward)
CareFusion (NYSE:CFN) Earnings History and Estimates Chart
CareFusion (NYSE CFN) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 2/5/2015 | Q215 | $0.79 | $0.99 | $1.0116 billion | $1.07 billion | View | N/A |  |
| 11/6/2014 | Q115 | $0.49 | $0.50 | $920.50 million | $922.00 million | View | N/A | |
| 8/7/2014 | Q414 | $0.72 | $0.79 | $1.04 billion | $1.1220 billion | View | Listen | |
| 5/5/2014 | Q314 | $0.62 | $0.60 | $986.67 million | $968.00 million | View | Listen | |
| 2/3/2014 | Q214 | $0.54 | $0.54 | $911.13 million | $922.00 million | View | Listen | |
| 11/7/2013 | Q1 2014 | $0.40 | $0.44 | $817.82 million | $830.00 million | View | N/A | |
| 8/8/2013 | Q4 2013 | $0.56 | $0.55 | $918.25 million | $903.00 million | View | Listen | |
| 5/9/2013 | Q3 2013 | $0.53 | $0.59 | $909.16 million | $901.00 million | View | Listen | |
| 2/8/2013 | Q1 2013 | $0.55 | $0.43 | | | View | N/A | |
| 8/9/2012 | | $0.50 | $0.51 | | | View | N/A | |
| 5/3/2012 | | $0.45 | $0.49 | | | View | N/A | |
| 2/2/2012 | | $0.43 | $0.44 | | | View | N/A | |
| 11/7/2011 | | $0.33 | $0.33 | | | View | N/A | |
| 8/8/2011 | | $0.50 | $0.52 | | | View | N/A | |
| 5/5/2011 | | $0.40 | $0.42 | | | View | N/A | |
| 2/3/2011 | | $0.37 | $0.44 | | | View | N/A | |
| 11/2/2010 | Q1 2011 | $0.30 | $0.30 | | | View | N/A | |
| 8/10/2010 | Q4 2010 | $0.37 | $0.38 | | | View | N/A | |
| 5/6/2010 | Q3 2010 | $0.33 | $0.26 | | | View | N/A | |
| 2/9/2010 | Q2 2010 | $0.38 | $0.39 | | | View | N/A | |
| 11/5/2009 | Q1 2010 | $0.26 | $0.39 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
CareFusion (NYSE:CFN) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
CareFusion (NYSE CFN) Insider Trading and Institutional Ownership History
CareFusion (NYSE CFN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/6/2015 | Jonathan Wygant | CAO | Sell | 1,700 | $59.79 | $101,643.00 | | |
| 2/6/2015 | Philip L Francis | Director | Sell | 40,980 | $59.89 | $2,454,292.20 | | |
| 12/15/2014 | Thomas J Leonard | Insider | Sell | 25,000 | $58.87 | $1,471,750.00 | | |
| 12/4/2014 | Donald Abbey | EVP | Sell | 1,000 | $59.35 | $59,350.00 | | |
| 11/12/2014 | J Michael Losh | Director | Sell | 12,630 | $57.32 | $723,951.60 | | |
| 10/6/2014 | James F Hinrichs | CFO | Sell | 20,000 | $56.91 | $1,138,200.00 | | |
| 10/6/2014 | Thomas J Leonard | Insider | Sell | 8,400 | $57.16 | $480,144.00 | | |
| 10/1/2014 | James F Hinrichs | CFO | Sell | 20,000 | $45.07 | $901,400.00 | | |
| 9/19/2014 | Thomas J Leonard | Insider | Sell | 16,600 | $47.01 | $780,366.00 | | |
| 9/15/2014 | Thomas J Leonard | Insider | Sell | 25,000 | $46.17 | $1,154,250.00 | | |
| 7/7/2014 | Thomas J Leonard | Insider | Sell | 1,250 | $45.47 | $56,837.50 | | |
| 7/1/2014 | Thomas J Leonard | Insider | Sell | 19,721 | $45.00 | $887,445.00 | | |
| 6/6/2014 | James F Hinrichs | CFO | Sell | 21,506 | $44.07 | $947,769.42 | | |
| 6/2/2014 | Thomas J Leonard | Insider | Sell | 1,250 | $42.81 | $53,512.50 | | |
| 5/29/2014 | Fortune Gordon La | EVP | Sell | 2,158 | $42.61 | $91,952.38 | | |
| 5/20/2014 | Kieran Gallahue | CEO | Sell | 100,000 | $42.98 | $4,298,000.00 | 305,122 | |
| 5/19/2014 | Fortune Gordon La | EVP | Sell | 38,738 | $42.70 | $1,654,112.60 | 20,894 | |
| 5/19/2014 | Thomas Leonard | Insider | Sell | 30,000 | $42.89 | $1,286,700.00 | 34,553 | |
| 5/5/2014 | Thomas Leonard | Insider | Sell | 1,250 | $39.06 | $48,825.00 | 34,553 | |
| 4/7/2014 | Thomas Leonard | Insider | Sell | 1,250 | $40.05 | $50,062.50 | 35,803 | |
| 4/4/2014 | Donald Abbey | EVP | Sell | 10,076 | $41.79 | $421,076.04 | 28,143 | |
| 3/3/2014 | Thomas Leonard | Insider | Sell | 1,250 | $40.26 | $50,325.00 | 37,053 | |
| 2/5/2014 | Philip Francis | Director | Buy | 6,500 | $38.61 | $250,965.00 | 4,515 | |
| 2/5/2014 | Thomas Leonard | Insider | Sell | 21,496 | $38.24 | $822,007.04 | 38,303 | |
| 1/9/2014 | Kieran Gallahue | CEO | Sell | 25,000 | $41.05 | $1,026,250.00 | 122,873 | |
| 1/6/2014 | Thomas Leonard | Insider | Sell | 1,250 | $39.48 | $49,350.00 | 59,799 | |
| 12/2/2013 | James Hinrichs | CFO | Sell | 28,078 | $40.13 | $1,126,770.14 | 27,024 | |
| 12/2/2013 | Kieran Gallahue | CEO | Sell | 25,000 | $40.09 | $1,002,250.00 | 147,873 | |
| 12/2/2013 | Thomas Leonard | Insider | Sell | 1,250 | $39.99 | $49,987.50 | 61,049 | |
| 11/4/2013 | Thomas J Leonard | Insider | Sell | 1,250 | $39.06 | $48,825.00 | | |
| 10/1/2013 | Thomas J Leonard | Insider | Sell | 1,250 | $36.99 | $46,237.50 | | |
| 9/9/2013 | Fortune Gordon La | EVP | Sell | 33,960 | $36.55 | $1,241,238.00 | | |
| 9/3/2013 | Thomas Leonard | Insider | Sell | 1,250 | $35.70 | $44,625.00 | 64,799 | |
| 8/26/2013 | J Michael Losh | Director | Sell | 53,311 | $35.67 | $1,901,603.37 | 32,858 | |
(Data available from 1/1/2013 forward)
CareFusion (NYSE CFN) News Headlines
| Source: |
|
CareFusion (NYSE:CFN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
CareFusion (NYSE:CFN) Income Statement, Balance Sheet and Cash Flow Statement
CareFusion (NYSE CFN) Stock Chart for Monday, April, 23, 2018
Loading chart…
